Schroder Investment Management Group Sells 189,618 Shares of Amdocs Limited $DOX

Schroder Investment Management Group cut its holdings in Amdocs Limited (NASDAQ:DOXFree Report) by 29.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 463,966 shares of the technology company’s stock after selling 189,618 shares during the quarter. Schroder Investment Management Group’s holdings in Amdocs were worth $37,550,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DOX. Amundi lifted its position in shares of Amdocs by 73.0% in the 1st quarter. Amundi now owns 13,778 shares of the technology company’s stock worth $1,217,000 after purchasing an additional 5,816 shares during the period. Millennium Management LLC increased its holdings in Amdocs by 458.3% during the first quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock valued at $6,135,000 after buying an additional 55,038 shares during the period. Goldman Sachs Group Inc. increased its holdings in Amdocs by 12.6% during the first quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock valued at $30,300,000 after buying an additional 37,087 shares during the period. Empowered Funds LLC raised its stake in Amdocs by 12.0% in the first quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock worth $1,462,000 after buying an additional 1,709 shares in the last quarter. Finally, Jane Street Group LLC raised its stake in Amdocs by 195.4% in the first quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock worth $10,608,000 after buying an additional 76,683 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.

Amdocs Stock Performance

Shares of DOX opened at $66.92 on Thursday. The stock has a 50-day moving average of $75.62 and a two-hundred day moving average of $79.47. Amdocs Limited has a one year low of $65.74 and a one year high of $95.41. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The stock has a market cap of $7.22 billion, a P/E ratio of 12.94, a P/E/G ratio of 1.20 and a beta of 0.42.

Amdocs (NASDAQ:DOXGet Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The company had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.15 billion. During the same period last year, the firm posted $1.66 EPS. Amdocs’s revenue for the quarter was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, research analysts predict that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.569 per share. This represents a $2.28 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend is Tuesday, March 31st. This is an increase from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s dividend payout ratio is currently 40.81%.

Analyst Ratings Changes

Several brokerages have issued reports on DOX. Bank of America dropped their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research report on Wednesday, November 12th. Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Finally, Stifel Nicolaus cut their target price on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, Amdocs currently has an average rating of “Moderate Buy” and a consensus target price of $92.33.

Read Our Latest Report on Amdocs

Amdocs Company Profile

(Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

See Also

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.